Hefty tariff plan: US consumers stand to lose, not us, says Indian drug-makers
The US plans to impose "small" tariffs on pharmaceutical imports, potentially raising them to 150-250% in 1-1.5 years. Indian drug makers warn of negative consequences for both countries, as they may struggle to absorb the extra cost. The US relies heavily on India for affordable and quality medicines, and high tariffs could lead to drug shortages.